logo
Select company
Select metric
9.08%Operating Margin
VS
Market
58
Sector
81
Industry
89
History
91
$ 8.34Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information

Ticker

GYRE

Company Name

GYRE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GYRE THERAPEUTICS INC - Operating Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GYRE - Operating % Historical data
DateOperating MarginOperating IncomeRevenues
6/30/20259.08%$ 9.27M$ 102.19M
3/31/202510.3%$ 10.37M$ 100.64M
12/31/202415.28%$ 16.16M$ 105.76M
9/30/2024-24.92%$ -47.68M$ 191.34M
6/30/2024-32.28%$ -53.53M$ 165.85M
3/31/2024-42.2%$ -59.34M$ 140.62M
12/31/2023-59.26%$ -67.23M$ 113.45M
9/30/20230%$ -44.26M$ 0
6/30/20230%$ -47.8M$ 0
3/31/20230%$ 6.27M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) Operating % stands at -277.61%.
  • Over the past 5 years, GYRE THERAPEUTICS INC's average Operating % has been -461.72%.
  • The median Operating % for GYRE THERAPEUTICS INC during this period was -157.47%
  • GYRE THERAPEUTICS INC reached its highest Operating % over the past 5 years at 350.96%.
  • The lowest Operating % recorded by GYRE THERAPEUTICS INC in the same timeframe -1399.47%

GYRE THERAPEUTICS INC's Operating % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Operating % Benchmarks
CompanyOperating %
PHAT : PHATHOM PHARMACEUTICALS INC -235.89%NAGE : NIAGEN BIOSCIENCE INC 14.33%ANAB : ANAPTYSBIO INC -69.94%TBPH : THERAVANCE BIOPHARMA INC -48.18%URGN : UROGEN PHARMA LTD -131.12%CRMD : CORMEDIX INC 40.6%NRIX : NURIX THERAPEUTICS INC -319.32%ZVRA : ZEVRA THERAPEUTICS INC -192.07%KURA : KURA ONCOLOGY INC -263.82%SAGE : SAGE THERAPEUTICS INC -461.33%

Definition of Operating Margin

[Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Op. Inc. / Revenues
(=) Operating %
Operating % for GYRE THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -52.52M ] / Revenues [ $ 18.92M ]
(=) Operating % [ -277.61% ]

GYRE - Operating Margin, Last 5 years

-1399.47%

Minimum

Jun 30, 2021

350.96%

Maximum

Sep 30, 2022

-461.72%

Average

-157.47%

Median

Operating % Benchmark Analysis

The chart above depicts the distribution of Operating % for companies in the Total Stock Market. The average Operating % of the companies is 9.05% with a standard deviation of 23.74%.
The following table provides additional summary stats:
Operating % in the Market:
filtered constituents3.27K
min-71.54%
max83.49%
average9.05%
median8.75%
std23.74%